Overview
Meeting: October 26-27 | In-Person
The DIA Canada Annual Meeting will provide an in-depth exploration of the current pharmaceutical, medical device, and diagnostic landscapes in Canada, emphasizing Canada’s pivotal role in global healthcare product development. Offering three specialized tracks on Regulatory, Clinical, and Safety and Pharmacovigilance, the meeting will cover topics spanning from Health Canada’s latest regulatory initiatives, international collaboration, and innovative clinical practices to approaches that harness AI in drug safety and increase representation from equity-denied groups.
Attendees will have the opportunity to engage with leaders and experts from academia, regulatory bodies, and the pharmaceutical and medical device industries by gaining insights into best practices, lessons learned, and strategies to address the challenges facing stakeholders in Canada.
While we develop our 2026 agenda, please take a moment to review the 2025 final agenda.
Participant Testimonials
Very meaningful topics, excellent speakers which allowed meaningful conversations. Size of the event also facilitates networking. - Véronique Lafrance, Senior Project Manager, Regulatory Affairs, Organon Canada
Amazing opportunity to meet PV and regulatory professionals from across Canada, learn about the challenges they face locally and in collaboration with their global affiliates. We enjoy being there every year! - Zenith PV – Exhibitor
The meeting presented a valuable learning opportunity, as we gained insights into best practices from different companies and heard the regulatory agency perspective. In addition to the professional development, DIA Canada 2024 provided an excellent networking platform to connect with peers and colleagues from across the industry and regulatory sphere. I really encourage others to join DIA's events and meetings in the future. - Vanessa Zapata, Associate Director, Regional Pharmacovigilance Officer, Merck Canada Inc.
Program Committee
-
Stephanie Anderson, MS Associate Director, Regulatory Affairs
Intrinsik Corp., Canada -
Mei Lam, BSN, RN Associate Director Consumer Safety Regions Americas
Haleon, Canada -
Yatika Kohli, PHD, MBA Chief Compliance and Strategy Officer
NoNO Inc, Canada -
Katalin Bertenyi, MSC Manager, Centre for Blood, Blood Products and Biotherapeutics
Health Canada, Canada -
Nessrine Hanna, MSC Director, Clinical Operations
AbCellera, Canada -
Foo-Lim Yeh Allergan Aesthetics, Neuroscience, and Specialty Head, Regulatory Affairs
AbbVie, Canada -
Erin Cherban Chief Clinical Research Officer
Centre For Advancing Health Outcomes/Ctn+, Canada -
Hocine Abid, MD, MBA National Manager, Regulatory Operations and Enforcement Branch
Health Canada, Canada -
Rosemarie Clarke, RN, PMP Translational & Clinical Research Consultant
AllWright-Clarke Research Solutions Inc., Canada -
Anna Bussel, MPHARM Vice President Pharmacovigilance and Medical Information
ClaroPV Services Inc, Canada -
Liliana Di Stabile, MD Safety Physician
Knight Therapeutics Inc., Canada -
Daniel Greco, PHARMD, MS, RPH Associate Director of Patient Safety
Bristol-Myers Squibb Company, Canada -
Ricardo Pasquel Cook, MD Safety Team Lead
Pfizer Inc., Canada -
Riti Singh, PHARMD, MBA National Director - Scientific Affairs, Quality, Ethics and Compliance
Bayshore Healthcare (Bayshore Specialty Rx Ltd.), Canada -
Yulia Vasianovich, PHD, RAC Scientific Evaluator, Marketed Health Products Directorate
Health Canada, Canada -
Sanyukta Kher Head of Reg Affairs
Mint Pharmaceuticals Inc., Canada -
Adesola Adeyemi, MSC Regulatory Affairs Project Manager
Bayer Inc., Canada -
Rebecca Humecky Associate Director Regulatory Affairs
Cytokinetics, United States -
Amy Chan Associate Director, Regulatory Affairs
Takeda Canada Inc., Canada -
Angelina Habimana Sr. Dir. Regulatory Affairs
Teva Canada Innovation, Canada -
Oxana Iliach, PHD Senior Director Regulatory Strategy
Certara, Canada -
Representative Invited DIA, Switzerland
Have an account?